No Luck for Chemo-Free Tx in First-Line Bladder Cancer
PD-L1 checkpoint blockade with or without anti-CTLA-4 failed to improve overall survival (OS) compared to standard chemotherapy in previously untreated metastatic bladder...
09/27/2020
- READ MORE
Innovators in Comprehensive Urological Care
Innovators in comprehensive urological care
Images Powered by 
Immunotherapy improves survival in patients with advanced bladder cancer
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a...
09/21/2020
- READ MORE
Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies.
There is an urgent need to provide a risk-stratification tool for intermediate-risk non-muscle-invasive bladder cancer (NMIBC), especially at the time of bacillus...
09/16/2020
- READ MORE
Chemo Plus Immunotherapy Shows Promise for Advanced Bladder Cancer
The combination of nivolumab, gemcitabine and cisplatin produces significant pathologic response rates in patients with muscle-invasive bladder cancer (MIBC) in the neoadjuvant...
09/09/2020
- READ MORE
Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review
Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a... Comparison of cross-sectional imaging techniques for the...
08/11/2020
- READ MORE
Why aren’t advanced bladder cancers being treated?
Newswise — Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder...
06/23/2020
- READ MORE
Bavencio Shows Benefit as 1st-line Maintenance Therapy for Bladder...
First-line maintenance therapy with Bavencio (avelumab) significantly delays disease progression or death in people with inoperable, locally advanced or metastatic urothelial...
06/21/2020
- READ MORE
Infigratinib Appears Active Across All Lines of Treatment in Patients With Advanced Bladder Cancer
Results of a retrospective analysis presented at the 2020 ASCO Virtual Scientific Program show that infigratinib demonstrates clinical activity in patients with metastatic...
06/20/2020
- READ MORE
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence BMC Urology volume 20, Article number: 64 (2020) Cite this article 91...
06/18/2020
- READ MORE
No Higher Death Risk with Fewer Cystoscopies for NIMBC
Low-intensity cystoscopic surveillance of high-risk non-muscle-invasive bladder cancer (NMIBC) led to fewer transurethral resections without increasing the risk of fatal bladder...
06/17/2020
- READ MORE
Can Mitomycin Gel Defer Surgery for Low-Grade Early Bladder Cancer?
Two thirds of patients with low-grade intermediate-risk non-muscle-invasive bladder cancer (NMIBC) achieved complete responses (CRs) and deferred surgery after primary...
06/16/2020
- READ MORE
Growth Factors Play Emerging Role in Bladder Cancer
When checkpoint inhibitorswere introduced, it had been more than 30 years since any new drugs had been approved for the treatment of urothelial cancer. Recently, 2 new...
06/12/2020
- READ MORE